Terms: = Kidney tumors AND SMARCA4, hSNF2b, 6597, P51532, BRG1, SNF2L4, SNF2, SWI2, FLJ39786, BAF190, SNF2LB, SNF2-BETA, ENSG00000127616
40 results:
1. [Cytopathological characteristics of smarca4-deficient thoracic undifferentiated tumors in serous effusion].
Wang WN; Liu XT; Liang YM
Zhonghua Bing Li Xue Za Zhi; 2024 Feb; 53(2):143-148. PubMed ID: 38281781
[No Abstract] [Full Text] [Related]
2. Tazemetostat in the therapy of pediatric INI1-negative malignant rhabdoid tumors.
Vejmelkova K; Pokorna P; Noskova K; Faustmannova A; Drabova K; Pavelka Z; Bajciova V; Broz M; Tinka P; Jezova M; Palova H; Kren L; Valik D; Slaby O; Sterba J
Sci Rep; 2023 Dec; 13(1):21623. PubMed ID: 38062114
[TBL] [Abstract] [Full Text] [Related]
3. PBRM1-deficient PBAF complexes target aberrant genomic loci to activate the NF-κB pathway in clear cell renal cell carcinoma.
Yao X; Hong JH; Nargund AM; Ng MSW; Heng HL; Li Z; Guan P; Sugiura M; Chu PL; Wang LC; Ye X; Qu J; Kwek XY; Lim JCT; Ooi WF; Koh J; Wang Z; Pan YF; Ong YS; Tan KY; Goh JY; Ng SR; Pignata L; Huang D; Lezhava A; Tay ST; Lee M; Yeo XH; Tam WL; Rha SY; Li S; Guccione E; Futreal A; Tan J; Yeong JPS; Hong W; Yauch R; Chang KT; Sobota RM; Tan P; Teh BT
Nat Cell Biol; 2023 May; 25(5):765-777. PubMed ID: 37095322
[TBL] [Abstract] [Full Text] [Related]
4. YAP-Activated SATB2 Is a Coactivator of NRF2 That Amplifies Antioxidative Capacity and Promotes Tumor Progression in Renal Cell Carcinoma.
Jin J; Chen F; He W; Zhao L; Lin B; Zheng D; Chen L; He H; He Q
Cancer Res; 2023 Mar; 83(5):786-803. PubMed ID: 36598364
[TBL] [Abstract] [Full Text] [Related]
5. Circadian lncRNA ADIRF-AS1 binds PBAF and regulates renal clear cell tumorigenesis.
Brooks R; Monzy J; Aaron B; Zhang X; Kossenkov A; Hayden J; Keeney F; Speicher DW; Zhang L; Dang CV
Cell Rep; 2022 Oct; 41(3):111514. PubMed ID: 36261012
[TBL] [Abstract] [Full Text] [Related]
6. Prevalence of SWI/SNF genomic alterations in cancer and association with the response to immune checkpoint inhibitors: A systematic review and meta-analysis.
Wang N; Qin Y; Du F; Wang X; Song C
Gene; 2022 Aug; 834():146638. PubMed ID: 35680019
[TBL] [Abstract] [Full Text] [Related]
7. Loss of PBRM1 Alters Promoter Histone Modifications and Activates ALDH1A1 to Drive Renal Cell Carcinoma.
Schoenfeld DA; Zhou R; Zairis S; Su W; Steinbach N; Mathur D; Bansal A; Zachem AL; Tavarez B; Hasson D; Bernstein E; Rabadan R; Parsons R
Mol Cancer Res; 2022 Aug; 20(8):1193-1207. PubMed ID: 35412614
[TBL] [Abstract] [Full Text] [Related]
8. Molecular Genetic Determinants of Shorter Time on Active Surveillance in a Prospective Phase 2 Clinical Trial in Metastatic Renal Cell Carcinoma.
Reig Torras O; Mishra A; Christie A; McKenzie T; Onabolu O; Singla N; Plimack ER; Suárez C; Ornstein MC; Alpaugh RK; Elias R; Bowman IA; McKay RM; Przybycin C; Kapur P; Brugarolas J; Rini B
Eur Urol; 2022 Jun; 81(6):555-558. PubMed ID: 34980496
[TBL] [Abstract] [Full Text] [Related]
9. Succinate Dehydrogenase-Deficient Renal Cancer Featuring Fructose-1,6-Biphosphatase Loss, Pyruvate Kinase M2 Overexpression, and SWI/SNF Chromatin Remodeling Complex Aberrations: A Rare Case Report.
Szymanski M; Rusetska N; Jancewicz I; Armatowska A; Ligaj M; Chrzan A; Hincza K; Kowalik A; Mika P; Kisiel M; Zolnierek J; Kosior J; Demkow T; Siedlecki JA; Sarnowski TJ; Sarnowska E
Oncologist; 2021 Sep; 26(9):e1652-e1655. PubMed ID: 34003534
[TBL] [Abstract] [Full Text] [Related]
10. Current recommendations for clinical surveillance and genetic testing in rhabdoid tumor predisposition: a report from the SIOPE Host Genome Working Group.
Frühwald MC; Nemes K; Boztug H; Cornips MCA; Evans DG; Farah R; Glentis S; Jorgensen M; Katsibardi K; Hirsch S; Jahnukainen K; Kventsel I; Kerl K; Kratz CP; Pajtler KW; Kordes U; Ridola V; Stutz E; Bourdeaut F
Fam Cancer; 2021 Oct; 20(4):305-316. PubMed ID: 33532948
[TBL] [Abstract] [Full Text] [Related]
11. Epithelioid Sarcoma Arising in a Long-Term Survivor of an Atypical Teratoid/Rhabdoid Tumor in a Patient With Rhabdoid Tumor Predisposition Syndrome.
Baker TG; Lyons MJ; Leddy L; Parham DM; Welsh CT
Pediatr Dev Pathol; 2021; 24(2):164-168. PubMed ID: 33470921
[TBL] [Abstract] [Full Text] [Related]
12. The SWI/SNF chromatin-remodeling complex status in renal cell carcinomas with sarcomatoid or rhabdoid features.
Kinoshita F; Kohashi K; Sugimoto M; Takamatsu D; Kiyozawa D; Eto M; Oda Y
Virchows Arch; 2020 Nov; 477(5):651-660. PubMed ID: 32447490
[TBL] [Abstract] [Full Text] [Related]
13. PBRM1 loss defines a nonimmunogenic tumor phenotype associated with checkpoint inhibitor resistance in renal carcinoma.
Liu XD; Kong W; Peterson CB; McGrail DJ; Hoang A; Zhang X; Lam T; Pilie PG; Zhu H; Beckermann KE; Haake SM; Isgandrova S; Martinez-Moczygemba M; Sahni N; Tannir NM; Lin SY; Rathmell WK; Jonasch E
Nat Commun; 2020 May; 11(1):2135. PubMed ID: 32358509
[TBL] [Abstract] [Full Text] [Related]
14.
Chetty R; Serra S
J Clin Pathol; 2020 May; 73(5):257-260. PubMed ID: 32312722
[TBL] [Abstract] [Full Text] [Related]
15. [Pathological and molecular features of malignancies underlined by BAF complexes inactivation].
Le Quang M; Ranchère-Vince D; Le Loarer F
Ann Pathol; 2019 Dec; 39(6):399-413. PubMed ID: 31255411
[TBL] [Abstract] [Full Text] [Related]
16. SWI/SNF protein expression status in fumarate hydratase-deficient renal cell carcinoma: immunohistochemical analysis of 32 tumors from 28 patients.
Agaimy A; Amin MB; Gill AJ; Popp B; Reis A; Berney DM; Magi-Galluzzi C; Sibony M; Smith SC; Suster S; Trpkov K; Hes O; Hartmann A
Hum Pathol; 2018 Jul; 77():139-146. PubMed ID: 29689242
[TBL] [Abstract] [Full Text] [Related]
17. Utility of multiphasic multidetector computed tomography in discriminating between clear cell renal cell carcinomas with high and low carbonic anhydrase-IX expression.
Young JR; Coy H; Kim HJ; Douek M; Sisk A; Belldegrun A; Pantuck AJ; Raman SS
Abdom Radiol (NY); 2018 Oct; 43(10):2734-2742. PubMed ID: 29520426
[TBL] [Abstract] [Full Text] [Related]
18. High expression of smarca4 or SMARCA2 is frequently associated with an opposite prognosis in cancer.
Guerrero-Martínez JA; Reyes JC
Sci Rep; 2018 Feb; 8(1):2043. PubMed ID: 29391527
[TBL] [Abstract] [Full Text] [Related]
19. SMARCB1-deficient tumors of Childhood: A Practical Guide.
Pawel BR
Pediatr Dev Pathol; 2018; 21(1):6-28. PubMed ID: 29280680
[TBL] [Abstract] [Full Text] [Related]
20. Renal cell tumors with clear cell histology and intact VHL and chromosome 3p: a histological review of tumors from the Cancer Genome Atlas database.
Favazza L; Chitale DA; Barod R; Rogers CG; Kalyana-Sundaram S; Palanisamy N; Gupta NS; Williamson SR
Mod Pathol; 2017 Nov; 30(11):1603-1612. PubMed ID: 28731045
[TBL] [Abstract] [Full Text] [Related]
[Next]
